CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its ...
CRISPR Therapeutics AG (NASDAQ:CRSP) is among the top 10 stocks to buy from Cathie Wood’s stock portfolio. CRISPR made up ...
2don MSN
Teens may have come up with a new way to detect, treat Lyme disease using CRISPR gene editing
To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...
Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...
To compile our list of the best short squeeze stocks, we made use of stocks screeners to note down stocks with significant ...
CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...
A single multipurpose gene-editing tool can correct several genetic conditions by restoring proteins that have been truncated ...
KOL panel to discuss how vispa-cel, an anti-CD19 allogeneic CAR-T cell therapy, can broaden access for patients with second-line large B cell lymphoma including through use in the community setting ...
13d
The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care
Detailed price information for Avant Technologies Inc (AVAI) from The Globe and Mail including charting and trades.
Detailed price information for Editas Medicine (EDIT-Q) from The Globe and Mail including charting and trades.
The advance anti-aging therapies market is expanding quickly fueled by a larger senior population and increased consumer focus on preventive and longevity-focused health. A report from Grand View ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback